Cassava Sciences, Inc. (SAVA) Financials

SAVA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 151.7 million 14.2 million
2023-09-30 172.5 million 17.4 million
2023-06-30 197.2 million 17.9 million
2023-03-31 218.1 million 14.1 million

SAVA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -22.4 million 2.1 million
2023-09-30 -26.6 million 949000
2023-06-30 -19.9 million 835000
2023-03-31 -13.6 million 673000

SAVA Net Income

No data available :(

SAVA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 121.1 million - -
2023-09-30 142.4 million - -
2023-06-30 168.4 million - -
2023-03-31 187.5 million - -

SAVA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 42.2 million
2023-09-30 42.0 million
2023-06-30 41.8 million
2023-03-31 41.7 million

SAVA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 41000 18.7 million 4.1 million 356000
2023-09-30 22000 23.6 million 4.3 million -
2023-06-30 6000 25.0 million 3.8 million -
2023-03-31 357000 22.1 million 4.4 million -

SAVA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.3 million 356000
2023-09-30 - 392000
2023-06-30 - 391000
2023-03-31 - 391000

SAVA

Price: $22.06

52 week price:
12.32
32.10

Earnings Per Share: -2.32 USD

P/E Ratio: -10.39

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 2.0 million

Market Capitalization: 983.8 million

Links: